Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 3, 1998

View Archived Issues

Calypte Biomedical to acquire assets of Cambridge Biotech

AMBI seeks partners to develop injectable nisin for treatment of hospital-acquired infections

Abgenix initiates a phase I/II clinical trial in patients with psoriasis

Bausch & Lomb to manufacture Lidakol for treatment of oral-facial herpes

Ascent to promote Warner-Lambert's Omnicef

AxyS initiates phase I studies of APC-2059 for treatment of acute inflammatory bowel disease

IntraBiotics receives milestone payment from Pharmacia & Upjohn

Adozelesin displays marginal efficacy in previously untreated metastatic breast cancer

Significant protection against ischemic injury in cortex of rats primed with estradiol

U.S. patent covers transgenically produced rhATIII

First clinical trial of human gene therapy for hemophilia begins

Genzyme General receives FDA approval for Thyrogen

Dyax and Genzyme General to develop new antiinflammatory treatment

Final marketing application filed for Ampligen in E.U.

rNAPc2 enters phase II trials in U.S. and Europe

Sanofi, Synthelabo plan another significant European drug company merger

Cytogen submits NDS for ProstaScint for approval in Canada and highlights new clinical data

MedImmune and Pasteur Merieux Connaught develop second-generation Lyme disease vaccine

Harris FRC establishes safety of candidate antiepileptic drug in volunteer studies

Second-generation PD diagnostic enters preclinical development at BLSI

Accutin, an RGD-containing peptide with angiogenesis-inhibitory activity

Health Canada approves first new incontinence medication in over a decade

Agents for ulcers synthesized and evaluated at Shiseido

American Home Products describes preferential COX-2 inhibitors

New HIV protease inhibitors in development at Monsanto

Pharmacokinetic studies support chronic dosing of FK-143

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...